HomeIMUX • NASDAQ
add
Immunic Inc
Previous close
$1.05
Day range
$1.00 - $1.10
Year range
$0.97 - $2.11
Market cap
92.78M USD
Avg Volume
861.98K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 25.73M | 9.15% |
Net income | -24.37M | -7.02% |
Net profit margin | — | — |
Earnings per share | -0.24 | 52.94% |
EBITDA | -25.68M | -9.13% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 59.07M | -1.04% |
Total assets | 64.76M | -3.31% |
Total liabilities | 23.54M | 26.78% |
Total equity | 41.22M | — |
Shares outstanding | 90.08M | — |
Price to book | 2.28 | — |
Return on assets | -85.04% | — |
Return on capital | -120.61% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -24.37M | -7.02% |
Cash from operations | -20.80M | -20.17% |
Cash from investing | -50.00K | -13.64% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -20.63M | -17.17% |
Free cash flow | -12.41M | -26.73% |
About
CEO
Founded
May 2003
Website
Employees
85
